T1	Organism 27 32	Human
T2	OrganismPart 33 38	Heart
T3	Disease 432 453	mitral valve prolapse
T4	Disease 455 458	MVP
*	Equiv T3 T4
T5	Disease 107 154	Dilated Left Atrium Without Atrial Fibrillation
T6	Disease 661 680	atrial fibrillation
T7	Disease 682 684	AF
T8	OrganismPart 713 724	right atria
T9	OrganismPart 726 728	RA
T10	OrganismPart 731 741	left atria
T11	OrganismPart 743 745	LA
T12	OrganismPart 751 765	left ventricle
T13	OrganismPart 767 769	LV
*	Equiv T8 T9
*	Equiv T10 T11
*	Equiv T12 T13
T14	NumberOfSamples 774 779	seven
T15	Sex 780 784	male
T16	Disease 831 862	dilated LA but no history of AF
T17	Chromatography 976 1025	reverse phase high-pressure liquid chromatography
T18	Instrument 1055 1077	Q-Exactive-HF Orbitrap
T19	Disease 3925 3946	mitral valve prolapse
T20	Disease 3948 3951	MVP
*	Equiv T19 T20
T21	OrganismPart 4012 4022	right (RA)
T22	OrganismPart 4027 4037	left atria
T23	OrganismPart 4039 4041	LA
*	Equiv T22 T23
T24	OrganismPart 4056 4070	left ventricle
T25	OrganismPart 4072 4074	LV
*	Equiv T24 T25
T26	Disease 4581 4600	atrial fibrillation
T27	Disease 4602 4604	AF
T28	Disease 4673 4701	dilated LA in a non-AF stage
T29	Treatment 4870 4902	mitral valve replacement surgery
T30	OrganismPart 4941 4943	LA
T31	OrganismPart 4948 4950	RA
T32	Disease 4969 4999	persistent atrial fibrillation
T33	OrganismPart 5119 5121	LV
T34	OrganismPart 5469 5471	LV
T35	OrganismPart 5484 5490	hearts
T36	NumberOfBiologicalReplicates 5990 5995	seven
T37	NumberOfSamples 6087 6089	21
T38	NumberOfBiologicalReplicates 6522 6527	three
T39	OrganismPart 7298 7300	LA
T40	OrganismPart 7302 7304	RA
T41	OrganismPart 7309 7311	LV
T42	Treatment 7335 7355	mitral valve surgery
T43	ReductionReagent 8467 8534	ris(2-carboxyethyl)phosphine (TCEP) and 10 mm chloroacetamide (CAA)
T44	Instrument 9694 9752	Q-Exactive HF quadrupole Orbitrap tandem mass spectrometer
T45	Chromatography 9644 9680	reversed-phase liquid chromatography
